Capital Change Notice
Capital Change Notice
Updated as at February 2025
Section 1: Issuer information
Name of issuer Promisia Healthcare Limited
NZX ticker code PHL
Class of financial product Ordinary Shares & Unquoted Restricted
Share Units (RSUs)
ISIN (If unknown, check on NZX website) NZPRPE0001S5
Currency NZD
Section 2: Capital change details
Number issued/acquired/redeemed Shares issued: 89,333
RSUs converted: 89,333
RSUs redeemed: 244,000
Nominal value (if any) N/A
Issue/acquisition/redemption price per security $0.3952 (being the 20 business day
VWAP of PHL’s ordinary shares prior to
the vesting date of the RSUs).
Nature of the payment (for example, cash or other
consideration)
Non-cash consideration provided in the
form of services rendered by the senior
executive of PHL.
Amount paid up (if not in full) N/A
Percentage of total class of Financial Products
issued/acquired/redeemed/ (calculated on the
number of Financial Products of the Class,
excluding any Treasury Stock, in existence)
1
Percentage of shares issued: 0.17%
Percentage of RSUs converted and
redeemed: 73.53%
For an issue of Convertible Financial Products or
Options, the principal terms of Conversion (for
example the Conversion price and Conversion date
and the ranking of the Financial Product in relation
to other Classes of Financial Product) or the Option
(for example, the exercise price and exercise date)
N/A
Reason for issue/acquisition/redemption and
specific authority for issue/acquisition/redemption/
(the reason for change must be identified here)
89,333 shares were issued upon the
conversion of RSUs in PHL issued under
the 2023 Promisia Healthcare Limited
Senior Executive Restricted Share Plan
Rules (RSU Plan Rules) and the
individual’s letter of invitation (Letter of
Invitation).
244,000 RSUs were redeemed and
cancelled in accordance with the RSU
Plan Rules.
1
The percentage is to be calculated immediately before the issue, acquisition, redemption or Conversion.
Total number of Financial Products of the Class
after the issue/acquisition/redemption/Conversion
(excluding Treasury Stock) and the total number of
Financial Products of the Class held as Treasury
Stock after the issue/acquisition/redemption.
Total number of shares on issue:
52,692,950 shares
Total number of RSUs on issue: 120,000
RSUs
In the case of an acquisition of shares, whether
those shares are to be held as treasury stock
N/A
Specific authority for the issue, acquisition, or
redemption, including a reference to the rule
pursuant to which the issue, acquisition, or
redemption is made
NZX Listing Rule 4.6.1, 4.9.1(b) and in
accordance with the terms of the Letter of
Invitation and the RSU Plan Rules.
Terms or details of the issue, acquisition, or
redemption (for example: restrictions, escrow
arrangements)
N/A
Date of issue/acquisition/redemption
2
11/04/2025
Section 3: Disclosure required for Placements made under Rule 4.5.1
Details of the approach in identifying investors who
were able to participate in the offer and how their
respective allocations in the offer were determined.
The explanation must set out the key objectives
and criteria the Issuer adopted in the allocation
process, whether one of those objectives was a
best effort to allocate on a pro rata basis to existing
holders of the Issuer’s Equity Securities, and any
significant exceptions or deviations from those
objectives and criteria.
N/A
Section 4: Authority for this announcement and contact person
Name of person
authorised to make this
announcement
Francisco Rodriguez-Ferrere
Contact person for this announcement Francisco Rodriguez-Ferrere
Contact phone number 021 245 1801
Contact email address info@promisia.co.nz
Date of release through MAP
14/04/2025
2
Continuous issuers using this form in reliance on Rule 3.13.2, please indicate the period during which the relevant
issue/acquisition/redemptions were made (for example, 1 January 2019 to 31 January 2019).
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- FPH — Fisher & Paykel Healthcare Corporation Limited: Capital Change Notices - NZ & AU ESPS2025-04-07
“Capital Change Notice 7 April 2025 Issue of ordinary shares This notice is given under NZX Listing Rule 3.13.1 and relates to the issue of ordinary shares in Fisher & Paykel Healthcare Corporation Limited (“FPH”) in connection with one or more of FPH’…”
- FPH — Fisher & Paykel Healthcare Corporation Limited: Capital Change Notice - North America ESPP2025-07-02
“Capital Change Notice 2 July 2025 Issue of ordinary shares This notice is given under NZX Listing Rule 3.13.1 and relates to the issue of ordinary shares in Fisher & Paykel Healthcare Corporation Limited (“FPH”) in connection with one or more of FPH’s…”
- FPH — Fisher & Paykel Healthcare Corporation Limited: Capital Change Notice - North America ESPP2025-04-02
“Capital Change Notice 3 April 2025 Issue of ordinary shares This notice is given under NZX Listing Rule 3.13.1 and relates to the issue of ordinary shares in Fisher & Paykel Healthcare Corporation Limited (“FPH”) in connection with one or more of FPH’…”